MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jacasi.2026.06.014

Медицинская библиотека · JACC. Asia · 2026

Prognostic Value of Persistent Microvascular Obstruction on Follow-Up Cardiac MRI After Reperfused STEMI.

Zhou Pengyu, Sa Fen, Aisikaier Kaisaierjiang, Wang Jiaxin, Dong Zhixiang, Ma Xuan, Tang Yun, Wei Zhuxin, Jia Xi, Chen Xingrui, Liu Yujie, Xu Wenqing, Yang Shujuan, Zhao Fengnian, Zhao Kankan, Lu Minjie, Chen Xiuyu, Zhao Shihua

СтатьяПеревод в очереди

Аннотация

BACKGROUND

The prognostic value of persistent microvascular obstruction (persistent-MVO) in ST-segment elevation myocardial infarction (STEMI) patients after percutaneous coronary intervention (PCI) remains unclear.

OBJECTIVES

To investigate the prognostic value of persistent-MVO in reperfused STEMI.

METHODS

Retrospectively analyzed 504 STEMI patients with primary PCI who underwent a follow-up cardiac magnetic resonance at ≥60 days after PCI. Persistent-MVO was defined as the presence of MVO on late gadolinium enhancement (LGE) imaging, which served as the study baseline. The endpoint was composite events of heart failure (HF), including HF-related death, heart transplantation, left ventricular assist device implantation, and HF hospitalization. Competing risk analysis was performed to address the possible influences of competing events.

RESULTS

Persistent-MVO was detected in 44 of 504 patients (8.7%). These patients demonstrated lower left ventricular ejection fraction, larger end-diastolic volume index, and larger LGE extent (all P < 0.05), compared with those without. During a median follow-up of 64.5 months (IQR: 45.0-79.4), 91 of 504 patients (18.1%) experienced the endpoint. Adding persistent-MVO to a model with NYHA functional class, left ventricular ejection fraction, and LGE extent improved model discrimination (C-index: from 0.78 [95% CI: 0.73-0.83] to 0.82 [95% CI: 0.77-0.86], P = 0.01), model fit (-2 log-likelihood: from 996.7 to 984.8, P < 0.001), and risk reclassification (continuous net reclassification improvement: 8.56% [95% CI: 2.60%-16.23%], P < 0.01), with decision curve analysis confirming net clinical benefit at 5 years.

CONCLUSIONS

Persistent-MVO was observed in 8.7% of STEMI patients at least 60 days after PCI and provided incremental value beyond established risk markers for predicting HF-related events.

Для цитирования: Zhou Pengyu, Sa Fen, Aisikaier Kaisaierjiang, Wang Jiaxin, Dong Zhixiang, Ma Xuan, Tang Yun, Wei Zhuxin, Jia Xi, Chen Xingrui, Liu Yujie, Xu Wenqing, Yang Shujuan, Zhao Fengnian, Zhao Kankan, Lu Minjie, Chen Xiuyu, Zhao Shihua. Prognostic Value of Persistent Microvascular Obstruction on Follow-Up Cardiac MRI After Reperfused STEMI.. JACC. Asia. 2026. DOI: 10.1016/j.jacasi.2026.06.014.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.